We had previously identified that pan-PAD inhibitor Cl-amidine reduced PHB expression somewhat following 1 h treatment, in addition to affecting post-translational deimination, in the two GBM cell lines under study [9], although such effects were more pronounced in the LN18 cell line [9]. Here, PADI4 is linked to glioblastoma.